Cite
Rapamycin Inhibits Re-Endothelialization after Percutaneous Coronary Intervention by Impeding the Proliferation and Migration of Endothelial Cells and Inducing Apoptosis of Endothelial Progenitor Cells.
MLA
Hai-Tao Liu, et al. “Rapamycin Inhibits Re-Endothelialization after Percutaneous Coronary Intervention by Impeding the Proliferation and Migration of Endothelial Cells and Inducing Apoptosis of Endothelial Progenitor Cells.” Texas Heart Institute Journal, vol. 37, no. 2, Apr. 2010, pp. 194–201. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=48855048&authtype=sso&custid=ns315887.
APA
Hai-Tao Liu, Fei Li, Wen-Yong Wang, Xiao-Jing Li, Yi-Meng Liu, Rui-An Wang, Wen-Yi Guo, & Hai-Chang Wang. (2010). Rapamycin Inhibits Re-Endothelialization after Percutaneous Coronary Intervention by Impeding the Proliferation and Migration of Endothelial Cells and Inducing Apoptosis of Endothelial Progenitor Cells. Texas Heart Institute Journal, 37(2), 194–201.
Chicago
Hai-Tao Liu, Fei Li, Wen-Yong Wang, Xiao-Jing Li, Yi-Meng Liu, Rui-An Wang, Wen-Yi Guo, and Hai-Chang Wang. 2010. “Rapamycin Inhibits Re-Endothelialization after Percutaneous Coronary Intervention by Impeding the Proliferation and Migration of Endothelial Cells and Inducing Apoptosis of Endothelial Progenitor Cells.” Texas Heart Institute Journal 37 (2): 194–201. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=48855048&authtype=sso&custid=ns315887.